Trial in Progress: REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase Ib Multi-Cohort Study of Combination Regimens for Patients with Relapsed/Refractory Multiple Myeloma

被引：3

作者：

Rodriguez Otero, Paula ^{[1
]}

Joseph, Nisha S. ^{[2
]}

Kumar, Shaji K. ^{[3
]}

Lee, Hans C. ^{[4
]}

Leleu, Xavier ^{[5
]}

Manier, Salomon ^{[6
]}

Dimopoulos, Meletios A. ^{[7
]}

Victoria Mateos, Maria ^{[8
]}

Oriol, Albert ^{[9
,10
]}

Bumma, Naresh ^{[11
,12
]}

Gong, Weiying ^{[13
]}

Roy, Pourab ^{[13
]}

Lorenc, Karen Rodriguez ^{[13
]}

Kroog, Glenn S. ^{[13
]}

Sarkaria, Shawn M. ^{[13
]}

机构：

[1] Clin Univ Navarra, Dept Hematol, Pamplona, Spain

[2] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Louisville, KY USA

[3] Mayo Clin, Rochester, MN USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Ctr Hosp Univ Poitiers, Poitiers, France

[6] CHRU Lille, Lille, France

[7] Alexandra Gen Hosp Athens, Athens, Greece

[8] Hosp Clin Univ Salamanca, Salamanca, Spain

[9] Hosp Germans Trias i Pujol, Inst Catala Oncol, Badalona, Spain

[10] Hosp Germans Trias i Pujol, Inst Josep Carreras, Badalona, Spain

[11] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA

[12] Solove Res Inst, Columbus, OH USA

[13] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-157713

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4444 / 4446

页数：3

共 50 条

[1] Trial in progress: linvoseltamab, a BCMAxCD3 bispecific antibody, in a Phase 1b multi-cohort study of combination regimens for patients with relapsed/refractory multiple myeloma
Rodriguez-Otero, Paula
Joseph, Nisha
Kumar, Shaji
Leleu, Xavier
Manier, Salomon
Dimopoulos, Meletios
Mateos, Maria-Victoria
Oriol, Albert
Bumma, Naresh
Gong, Weiying
Roy, Pourab
Lorenc, Karen Rodriguez
Kroog, Glenn
Sarkaria, Shawn
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S60 - S60
[2] Trial in Progress: A Phase II Window of Opportunity Study of the BCMAxCD3 Bispecific Antibody REGN5458 in Previously Untreated Patients with Symptomatic Multiple Myeloma
Ferreri, Christopher J.
Quatela, Steven E.
Aina, Sean
Roy, Pourab
Boyapati, Anita
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Orlowski, Robert Z.
BLOOD, 2022, 140 : 10129 - 10130
[3] Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study
Bumma, Naresh
Richter, Joshua
Brayer, Jason
Zonder, Jeffrey A.
Dhodapkar, Madhav
Shah, Mansi R.
Hoffman, James E.
Mawad, Raya
Maly, Joseph J.
Lentzsch, Suzanne
Suvannasankha, Attaya
Roy, Pourab
Dey, Jyotirmoy
Chokshi, Dhruti
Boyapati, Anita
Visich, Jenn
Houvras, Yariv
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Jagannath, Sundar
BLOOD, 2022, 140 : 10140 - 10141
[4] Early, deep, and durable responses, and low rates of cytokine release syndrome with REGN5458, a BCMAxCD3 bispecific antibody, in a Phase 1/2 study in patients with relapsed/refractory multiple myeloma
Zonder, Jeffrey
Richter, Joshua
Bumma, Naresh
Brayer, Jason
Hoffman, James E.
Bensinger, William I.
Wu, Ka Lung
Xu, Linzhi
Chokshi, Dhruti
Boyapati, Anita
Cronier, Damien
Houvras, Yariv
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Dhodapkar, Madhav V.
Lentzsch, Suzanne
Cooper, Dennis
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S35 - S35
[5] Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome With REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase 1/2 First-In-Human Study in Patients With Relapsed/Refractory Multiple Myeloma
Zonder, Jeffrey A.
Richter, Joshua
Bumma, Naresh
Brayer, Jason
Hoffman, James E.
Bensinger, William I.
Wu, Ka Lung
Xu, Linzhi
Chokshi, Dhruti
Boyapati, Anita
Cronier, Damien
Houvras, Yariv
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Dhodapkar, Madhav V.
Lentzsch, Suzanne
Cooper, Dennis
Jagannath, Sundar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S406 - S407
[6] Early, Deep, and Durable Responses, and Low Rates of Cytokine Release Syndrome with REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 First-in-Human Study in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Zonder, Jeffrey A.
Richter, Joshua
Bumma, Naresh
Brayer, Jason
Hoffman, James E.
Bensinger, William I.
Wu, Ka Lung
Xu, Linzhi
Chokshi, Dhruti
Boyapati, Anita
Sharma, Manish
Lorenc, Karen Rodriguez
Kroog, Glenn S.
Dhodapkar, Mahdav V.
Lentzsch, Suzanne
Cooper, Dennis
Jagannath, Sundar
BLOOD, 2021, 138
[7] REGN5458, a BCMA x CD3 Bispecific Monoclonal Antibody, Induces Deep and Durable Responses in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
Madduri, Deepu
Rosko, Ashley
Brayer, Jason
Zonder, Jeffrey
Bensinger, William I.
Li, Jingjin
Xu, Linzhi
Adriaens, Lieve
Chokshi, Dhruti
Zhang, Weijiang
Boyapati, Anita
Sharma, Manish
Seebach, Frank
Sirulnik, L. Andres
Weinreich, David M.
Yancopoulos, George D.
Dhodapkar, Madhav V.
Lentzsch, Suzanne
Cooper, Dennis
Jagannath, Sundar
BLOOD, 2020, 136
[8] Safety and Preliminary Clinical Activity of REGN5458, an Anti-Bcma x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
Cooper, Dennis
Madduri, Deepu
Lentzsch, Suzanne
Jagannath, Sundar
Li, Jingjin
Boyapati, Anita
Adriaens, Lieve
Chokshi, Dhruti
Zhu, Min
Lowy, Israel
Weinreich, David M.
Yancopoulos, George D.
Sharma, Manish
Karasarides, Maria
Sternberg, David
BLOOD, 2019, 134
[9] LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma.
Lee, Hans C.
Bumma, Naresh
Richter, Joshua Ryan
Dhodapkar, Madhav V.
Hoffman, James E.
Suvannasankha, Attaya
Zonder, Jeffrey A.
Shah, Mansi R.
Lentzsch, Suzanne
Maly, Joseph J.
Ye, Jing Christine
Wu, Ka Lung
DeVeaux, Michelle
Chokshi, Dhruti
Boyapati, Anita
Hazra, Anasuya
Rodriguez-Lorenc, Karen
Kroog, Glenn Scott
Houvras, Yariv J.
Jagannath, Sundar
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[10] REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells
Dilillo, David J.
Olson, Kara
Mohrs, Katja
Meagher, T. Craig
Bray, Kevin
Sineshchekova, Olga
Startz, Thomas
Retter, Marc
Godin, Stephen
Delfino, Frank
Lin, John
Smith, Eric
Thurston, Olin Gavin
Kirshner, Jessica R.
BLOOD, 2018, 132

← 1 2 3 4 5 →